We look forward to exhibitat EuroMedLab 2021, the XXIV IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which has ben rescheduled due to the COVID-19 pandemic to April 11th to April 13th 2022.

We hope to see you at our booth #201.

SARS-CoV-2 Total Antibody Immunoassay at booth #201

In the effort to restrain the COVID-19 pandemic, serological testing to detect SARS-CoV-2 specific antibodies will be important in disease and community management. Please come by our booth #201 or book a meeting in advance if you are interested to learn more about our SARS-CoV-2 Total Antibody Immunoassay.


SARS-CoV-2 Total Antibody Immunoassay - Now on clinical chemical analysers

Gentian has developed a turbidimetric SARS-CoV-2 Total Antibody Immunoassay in collaboration with the University in Tromsø (UiT), Norway. The quantitative antibody test captures the full immune response detecting antibodies targeting the S1-subunit with high sensitivity and specificity. It will be calibrated against the international WHO international standard.


Get in touch for more information about Gentian SARS-CoV-2 Total Antibody Immunoassay

Let us know if you want more information about the assay or want to validate the assay in your laboratory. Please send us an email to marketing@gentian.com or fill out the form below. Our Product Manager for SARS-CoV-2 Total Antibody Immunoassay will get in touch.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Gentian Diagnostics AS published this content on 06 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 April 2022 06:51:04 UTC.